SCHEMBL12889451

SCHEMBL12889451

Cc1ccc(-c2cc(F)c(OC(F)(F)F)c(F)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 2/20 0.39
AR P10275 1/20 0.37
GPR3 P46089 1/20 0.36
PTGS2 P35354 2/20 0.34
PTPN5 P54829 1/20 0.34
KIF11 P52732 2/20 0.33
MAPT P10636 2/20 0.33
AURKA O14965 1/20 0.33
TPX2 Q9ULW0 1/20 0.33
RPS6KA3 P51812 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDK2 Q15119 1/20 0.33
PTGS1 P23219 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4567627 0.89 ALOX5AP (0.39) CYP11B1CYP11B2ARGPR3PTGS2
SCHEMBL13265423 0.89 ALOX5AP (0.39) CYP11B1CYP11B2ARGPR3PTGS2
SCHEMBL10018743 0.87 CYP11B1 (0.32) CYP11B1CYP11B2ARGPR3MAPT
SCHEMBL17834033 0.80 CYP11B1 (0.34) CYP11B1CYP11B2ARPTPN5KIF11
SCHEMBL12889521 0.80 PDE2A (0.45) CYP11B1CYP11B2ARPTPN5KIF11
SCHEMBL14075239 0.80 FFAR4 (0.35) PDK2
SCHEMBL10052628 0.80 ACHE (0.36) GPR3MAPTKDM4EALDH1A1ACHE
SCHEMBL17210772 0.78 PDE2A (0.41) CYP11B1CYP11B2MAPTKDM4ENPC1
SCHEMBL17550032 0.78 KIF11 (0.46) KIF11AURKATPX2
SCHEMBL20118151 0.78 ALOX5AP (0.37) CYP11B1CYP11B2GPR3PTGS2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7888519-B2 Liquid crystals; using metastasis catalysts; reduction, hydrogenation MERCK PATENT GESELLSCHAFT (DE) 2011-02-15 US disclosed
US-7888519-B2 Liquid crystals; using metastasis catalysts; reduction, hydrogenation MERCK PATENT GESELLSCHAFT (DE) 2011-02-15 US disclosed
US-7314943-B2 Pyran derivatives containing an exocyclic double bond MERCK PATENT GMBH (DE) 2008-01-01 US disclosed
US-7314943-B2 Pyran derivatives containing an exocyclic double bond MERCK PATENT GMBH (DE) 2008-01-01 US disclosed